Epilepsy, a chronic neurological disorder, is characterized by recurrent seizures. The last decade has seen significant advancements in its management. This article aims to provide a comprehensive update on these developments for healthcare professionals.
The past decade has witnessed the introduction of several new AEDs. These drugs, including Brivaracetam, Perampanel, and Lacosamide, have shown improved seizure control and fewer side effects compared to older drugs. They offer new mechanisms of action and are often effective in patients who are resistant to traditional AEDs.
Neuromodulation devices, such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS), have proven effective in reducing seizure frequency. They provide an alternative treatment option for patients who are not candidates for epilepsy surgery or those who have not responded to AEDs.
Advancements in neuroimaging and surgical techniques have improved the outcomes of epilepsy surgery. Minimally invasive procedures, such as Laser Interstitial Thermal Therapy (LITT), allow for precise ablation of epileptogenic zones with reduced morbidity. Furthermore, stereotactic EEG enables accurate localization of seizure foci, increasing the success rate of surgical interventions.
Genetic testing has emerged as a critical tool in the management of epilepsy. It allows for the identification of specific genetic mutations associated with epilepsy syndromes, facilitating personalized treatment plans. Moreover, it can provide valuable information for genetic counseling.
The advancements in epilepsy management have revolutionized the approach to this complex neurological disorder. The introduction of new AEDs, neuromodulation devices, improved surgical techniques, and genetic testing have significantly improved patient outcomes. It is essential for healthcare professionals to stay updated with these advancements to provide optimal care for patients with epilepsy.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation